Commentary

More Than Skin Deep

Dermatologists have traditionally regarded psoriasis as a skin disease. In the past several years, however, a growing body of data has suggested that psoriasis is associated with systemic comorbidities, including metabolic syndrome and increased cardiovascular risk. Psoriasis, in both its skin and joint manifestations, represents a major healthcare issue as an indicator of a broader underlying disorder of systemic inflammation; therefore, more comprehensive studies should be conducted to evaluate the pathophysiology, epidemiology, and treatment of psoriasis in relation to comorbid conditions.


 

Recommended Reading

Minocycline Joins List of Lupus-Inducing Drugs
MDedge Dermatology
Bullous Pemphigoid Managed With Methotrexate
MDedge Dermatology
Autoantibodies for Bullous Pemphigoid Found in Unaffected
MDedge Dermatology
Bullous Pemphigoid and Pemphigus Vulgaris Rates Climbing in U.K.
MDedge Dermatology
Vitamin D, Estrogen May Be Key to New SLE Tx
MDedge Dermatology
Autoimmune Testing Helps Guide Urticaria Tx
MDedge Dermatology
Prevalence of Mood and Sleep Problems in Chronic Skin Diseases: A Pilot Study
MDedge Dermatology
A Single-Center, Double-Blind, Randomized Trial of the Atrophogenic Effects of Fluocinonide Cream 0.1% Versus Clobetasol Propionate Cream 0.05% in Participants With Corticosteroid-Responsive Dermatoses
MDedge Dermatology
A New Standardized Method of Evaluating Cutaneous Irritation From Topical Medications
MDedge Dermatology
Psoriasis in the Patient With Human Immunodeficiency Virus, Part 1: Review of Pathogenesis
MDedge Dermatology